Description Of Stress Levels In Pulmonary Tuberculosis Patients Undergoing The Intensive Phase Of Treatment In Hospital And Puskesmas

Authors

  • Joseph Partogi Sibarani Department of Internal Medicine, Faculty of Medicine, Universitas HKBP Nommensen

DOI:

https://doi.org/10.51601/ijhp.v4i4.290

Abstract

The purpose of this study is to characterize the amount of stress experienced by tuberculosis patients receiving intensive phase therapy in hospitals and healthcare facilities. This study has a cross sectional design and is a descriptive observational study. 100 samples of tuberculosis patients who were receiving intense phase treatment were used in this investigation. With the consecutive sampling technique, how to choose the sample. Direct interviews with the research sample were used to gather data. Utilizing univariate analysis, research data were examined. According to the study's findings, 75% of the research sample's participants were men and 25% were women. The majority 26% are between the ages of 56 and 65. Up to 42% of people are receiving treatment for 6 to 8 weeks. The majority of pulmonary tuberculosis patients (33%) were found to have moderate levels of stress. Patients with pulmonary tuberculosis who were male, aged 36 to 45, and receiving treatment for the disease for six to eight weeks were found to have the most mild levels of stress. The study's findings indicate that the most mild levels of stress are felt by tuberculosis patients who are undergoing the intensive phase of therapy.

References

. Amin Z, Bahar A. Buku Ajar Ilmu Penyakit Dalam. 6 ed. Setiati S, Alwi I, Sudoyo AW, Simadibrata M, Setyohadi B, Syam AF, editor. Jakarta: Internal Publishing; 2014. 863 hal.

WHO. TB burden report 2018 [Internet]. Vol. 63, World Health Organization. 2018. 1–2 hal. Tersedia pada: https://apps.who.int/iris/handle/10665/274453

Kemenkes. Pedoman Nasional Pelayanan Kedokteran Tata Laksana Tuberkulosis. 2019;9–37.

Kemenkes. Kementerian Kesehatan Republik Indonesia. Kementeri Kesehat RI [Internet]. 2019;1(1):81. Tersedia pada: https://www.kemkes.go.id/article/view/19093000001/penyakit-jantung-penyebab-kematian-terbanyak-ke-2-di-indonesia.html

RI K. Riset Kesehatan Dasar. jakarta; 2013. 104 hal.

Sumatera Utara DK. Profil Provinsi Sumatera Utara. J Ilm Smart. 2019;III(2):149–50.

RI K. Pedoman Nasional Pelayanan Kedokteran Tata Laksana Tuberkulosis. 2020;28.

Fink G. Stress: Concepts, Definition and history. Encycl Neurosci. 2017;(October):549–55.

Stults-Kolehmainen MA, Sinha R. The effects of stress on physical activity and exercise. Vol. 44, Sports Medicine. new haven; 2015. 3 hal.

Hawari D. Manajemen Stres, Cemas, dan Depresi. 2 ed. jakarta: Indonesia, Balai Penerbit Fakultas Kedokteran Universitas; 2018. 3–11 hal.

Diamanta ADS, Agnes M, Buntoro IF. Hubungan Tingkat Stres dan Tingkat Pendapatan Dengan Kualitas Hidup Penderita Tuberkulosis Paru di Kota Kupang. Cendana Med J. 2020;19(1):44–50.

Putri NE, Kholis FN, Ngestiningsih D. Hubungan Tingkat Stres Dengan Kualitas Hidup Pada Pasien Tuberkulosis Di Rsup Dr. Kariadi Semarang. Diponegoro Med J (Jurnal Kedokt Diponegoro). 2018;7(2):499–506.

Selestina Mikan, Veronika A. Jelatu WA. Gambaran Tingkat Stres Pasien Remaja Penderita Tb Paru Di Polituberkulosis Paru Puskesmas Sentanikabupaten Jayapura. 2021

Hawari D. Manajemen Stres Cemas dan Depresi. 2 ed. jakarta: Badan Penerbit Fakultas Kedokteran Universitas Indonesia; 2021. 3–11

Fink G. Stress: Definition and history. Encycl Neurosci. 2009;(January 2010):549–55.

Sherwood L. Fisiologi Manusia. 8 ed. Alexander S, Glubka A, Crosby L, editor. Yolanda Cossio; 2013. 738–739 hal.

Bienertova-Vasku J, Lenart P, Scheringer M. Eustress and Distress: Neither Good Nor Bad, but Rather the Same? BioEssays. 2020;42(7):1–5.

Scales S, Foundation P. Reference : Lovibond, S.H. & Lovibond, P.f. (1995). Manual for the Depression anxiety Stress Scales. (2nd Ed) Sydney: Psychology Foundation. 1995;(0):1–5.

Trisnawati EA, Wicaksono DA. Hubungan antara Gangguan Emosional dengan Emotional Eating dan External Eating pada Masa Pandemi COVID-19. Bul Ris Psikol dan Kesehat Ment. 2021;1(2):1282–9.

Agustin retno ardanari. Tuberkulosis. 1 ed. yogyakarta: deepublish publisher; 2021. 27–28 hal.

Amin Z, asril bahar. Buku Ajar Ilmu Penyakit Dalam. 6 ed. Alwi I, Sudoyo aru w, Simadibrata M, Setyohadi B, Fahrial A, editor. jakarta: Interna Publishing; 2014. 863–871 hal.

Sembiring SPK. Indonesia bebas Tuberkulosis. 1 ed. Awahita R, editor. Sukabumi: Jejak Publisher; 2019. 23 hal.

Abbas A. Monitoring Efek Samping Obat Anti-Tuberkulosis (OAT) Pada Pengobatan Tahap Intensif Penderita TB Paru Di Kota Makassar. J Agromedicine Med Sci. 2017;3(1):19–24.

Tika Maelani dan, Cahyati widya hary. Karakteristik Penderita, Efek Samping Obat dan Putus Berobat Tuberkulosis Paru. Higeia J Public Heal Res Dev. 2019;3(2):227–38.

Sherwood L. Fisiologi Manusia. 8 ed. Cossio Y, editor. 2013. 738–739 hal.

Priyoto. Konsep manajemen stress. 2014

Aliflamra I, Wati YR, Rahimah SB. Hubungan Lama Pengobatan dengan Tingkat Stres pada Pasien Tuberkulosis Paru di RSUD Al – Ihsan Kabupaten Bandung Periode Maret – Mei 2016 The Relationship Between Duration of Treatment with Stress Levels In Pulmonary Tuberculosis Patient at The General Ho. 2016;746–51.

Saraswati F, Murfat Kz, Rasfayanah, Wiriansya EP, Akib MN. Karakteristik Penderita Tuberkulosis Paru Yang Relaps Di RS Ibnu Sina Makassar. 2022;2(2):109–15.

Rahman S. Faktor-Faktor Yang Mendasari Stres Pada Lansia. J Penelit Pendidik. 2016;16(1).

Makwa DJ, Hidayati E, Profesi MP, Klinis BP, Psikologi F, Dahlan UA. Relaksasi untuk Mengatasi Stres Sehari-hari pada Lansia. Naskah Pros Temilnas XI IPPI. 2019;(September):20–1.

Ukat DF. Hubungan Jenis Kelamin dan Lama Pengobatan Terhadap Stres Pada Pasien Tuberkulosis Paru di Puskesmas Oesapa Kota Kupang. Skripsi. 2017;42.

Zahroh C, Subai’ah S. Hubungan Lama Pengobatan Tbc Dengan Tingkat Stres Penderita Tbc Di Puskesmas Tambelangan Kabupaten Sampang. J Heal Sci. 2018;9(2):138–45.

Downloads

Published

2024-11-26

How to Cite

Partogi Sibarani, J. (2024). Description Of Stress Levels In Pulmonary Tuberculosis Patients Undergoing The Intensive Phase Of Treatment In Hospital And Puskesmas. International Journal of Health and Pharmaceutical (IJHP), 4(4), 595–602. https://doi.org/10.51601/ijhp.v4i4.290